Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User.
| Autor: | Litenski MN; Department of Psychiatry and Behavioral Health, Florida International University, Herbert Wertheim College of Medicine, Miami, USA., O'Reardon AB; Department of Psychiatry and Behavioral Health, Florida International University, Herbert Wertheim College of Medicine, Miami, USA., Pabon N; Department of Psychiatry, Mount Sinai Medical Center, Miami, USA., Hernandez M; Department of Psychiatry, Mount Sinai Medical Center, Miami, USA., Niyazov Y; Department of Psychiatry, Mount Sinai Medical Center, Miami, USA., Cruz J; Department of Psychiatry, Mount Sinai Medical Center, Miami, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 May 04; Vol. 16 (5), pp. e59641. Date of Electronic Publication: 2024 May 04 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.59641 |
| Abstrakt: | MDMA (3,4-methylenedioxymethamphetamine), also known as Ecstasy, is a synthetic amphetamine with hallucinogenic and stimulant properties, which has become increasingly favored as a substance for recreational use. Despite its deceptive reputation as "safe," chronic MDMA use is associated with neuropsychiatric complications, including psychosis. We describe a case of a 23-year-old woman with chronic MDMA use disorder and childhood trauma, who presented with severe psychosis and catatonic features. While initial diagnostic possibilities included drug-induced psychosis and mood disorders, the patient's history and presentation supported a diagnosis of bipolar I disorder with psychotic features, which was exacerbated by MDMA use. Conventional antipsychotics failed to improve psychotic symptoms and led to worsening of catatonia, requiring electroconvulsive therapy (ECT) for improvement. Socioeconomic barriers hindered follow-up care, leading to an Emergency Department (ED) admission shortly after discharge. This case highlights the intricate interplay between substance use, psychiatric illness, and trauma, and showcases ECT's efficacy in severe psychosis. It emphasizes the necessity for comprehensive mental health services, especially for vulnerable populations, and calls for further research into MDMA's psychiatric effects and optimal treatment approaches for individuals with co-occurring substance use and psychiatric disorders. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Litenski et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|